Medication info
Pimavan ES Tablet 30/2.5 mg (Pimasartan, Amlodipine)

Pimavan ES Tablet 30/2.5 mg (Pimasartan, Amlodipine)

Prescription medicationTabletOral
Ingredient · strength
S-Amlodipine Besylate Dihydrate›3.69mg / 1 tabletFimasartan Potassium Trihydrate›33.005mg / 1 tablet
Manufacturer / importer
Hana Pharmaceutical Co., Ltd.
Appearance
White, round, film-coated tablet with a square shape
Packaging
Bottle packaging - 30 tablets/bottle, Bottle packaging - 300 tablets/bottle
Approval status
Active

MFDS item code 202204663 · Approved 2022.12.27 · Insurance code 657807830

Summary

Main use
Treatment of essential hypertension not controlled with fimasartan monotherapy
Who takes it
Adults · Children
Adult dose
The recommended dose is 1 tablet once daily, taken with water, with or without food. It is recommended that the tablet be taken at the same time each day (e.g., in the morning), if possible. Before starting this medicine, it is recommended that the dose be adjusted using fimasartan; however, if blood pressure is not controlled as described below, a direct switch to this medicine may be considered. ㆍ 30/2.5 mg: For patients whose blood pressure is not adequately controlled with fimasartan 30 mg monotherapy. ㆍ 60/2.5 mg: For patients whose blood pressure is not adequately controlled with fimasartan 60 mg monotherapy. Patients taking fimasartan and S-amlodipine (amlodipine) concomitantly may switch to this medicine (a combination product containing the same amount of each active ingredient) for convenience. Elderly patients No initial dosage adjustment is required for elderly patients aged 70 years or younger. Patients with renal impairment No dosage adjustment is required in patients with mild to moderate renal impairment (creatinine clearance 30 ~ 80 mL/min); however, in patients with severe renal impairment (creatinine clearance < 30 mL/min), treatment should be initiated with fimasartan 30 mg in this medicine. Patients with hepatic impairment No dosage adjustment is required in patients with mild hepatic impairment; however, this medicine should not be administered to patients with moderate to severe hepatic impairment.
Child dose
The safety and efficacy in pediatric and adolescent patients aged 18 years or younger have not been established.

Ingredients

Manufacturer
Hana Pharmaceutical Co., Ltd.

Efficacy & effects

Treatment of essential hypertension not controlled with fimasartan monotherapy

  • Essential hypertension
View approved original text

This medication is used for patients with essential hypertension whose blood pressure is not adequately controlled with Pimasartan alone. It serves as an additional treatment option for cases where single-drug therapy is insufficient for blood pressure control. This helps to manage blood pressure more effectively and reduce the risk of complications due to hypertension.

How to take

Adult dose

The recommended dose is 1 tablet once daily, taken with water, with or without food. It is recommended that the tablet be taken at the same time each day (e.g., in the morning), if possible. Before starting this medicine, it is recommended that the dose be adjusted using fimasartan; however, if blood pressure is not controlled as described below, a direct switch to this medicine may be considered. ㆍ 30/2.5 mg: For patients whose blood pressure is not adequately controlled with fimasartan 30 mg monotherapy. ㆍ 60/2.5 mg: For patients whose blood pressure is not adequately controlled with fimasartan 60 mg monotherapy. Patients taking fimasartan and S-amlodipine (amlodipine) concomitantly may switch to this medicine (a combination product containing the same amount of each active ingredient) for convenience. Elderly patients No initial dosage adjustment is required for elderly patients aged 70 years or younger. Patients with renal impairment No dosage adjustment is required in patients with mild to moderate renal impairment (creatinine clearance 30 ~ 80 mL/min); however, in patients with severe renal impairment (creatinine clearance < 30 mL/min), treatment should be initiated with fimasartan 30 mg in this medicine. Patients with hepatic impairment No dosage adjustment is required in patients with mild hepatic impairment; however, this medicine should not be administered to patients with moderate to severe hepatic impairment.

Child dose

The safety and efficacy in pediatric and adolescent patients aged 18 years or younger have not been established.

Precautions

This medication can cause serious harm or death to the fetus and newborn if taken during pregnancy, especially in the second and third trimesters, so it should be discontinued immediately upon confirmation of pregnancy. Patients who are allergic to any of the ingredients in this medication, those who are pregnant or breastfeeding, patients undergoing renal dialysis, patients with moderate to severe liver function impairment, individuals with biliary obstruction, specific diabetes patients, and those with genetic conditions such as lactose intolerance should not take this medication. Patients with low blood volume or salt deficiency may experience hypotension when starting this medication or increasing the dose, so their condition should be closely monitored. Caution is also required for patients with impaired kidney function or renovascular hypertension. This medication can cause side effects such as dizziness, headache, facial or peripheral edema, urinary disorders, insomnia, and flushing. Rarely, serious kidney issues, hypotension, liver function anomalies, and other complications have been reported. If symptoms of hypotension occur during treatment, immediate measures, such as lying the patient down and administering fluids if necessary, are required. Regular blood tests are recommended due to the risk of elevated potassium levels. This medication may interact with other antihypertensives, diuretics, potassium-sparing diuretics, certain antibiotics, lithium, grapefruit juice, etc., so it is essential to discuss any medications being taken with a physician or pharmacist. Women who are pregnant or breastfeeding should avoid taking this medication and should consult a healthcare professional if pregnancy is confirmed. Safety and efficacy for children and adolescents under 18 years old have not been established, thus its use is not recommended. Elderly patients may respond more sensitively to this medication, thus caution is advised during use. Patients with moderate to severe liver impairment should not take this medication. In cases of overdose, severe hypotension, palpitations, and bradycardia may occur, and immediate medical attention should be sought if these symptoms arise. This medication should be kept out of reach of children, and transferring it to another container may cause quality deterioration or accidents, so caution is advised.

Side effects

  • Dizziness
  • orthostatic dizziness
  • headache
  • facial edema
  • peripheral edema
  • urination disorders
  • insomnia
  • flushing
  • syncope
  • sedation
Show 136 more
  • migraine
  • dyspepsia
  • vomiting
  • nausea
  • upper abdominal pain
  • weakness
  • foreign body sensation
  • increased liver enzyme levels
  • decreased platelet count
  • increased serum creatine phosphokinase
  • cough
  • muscle contraction
  • muscular rigidity
  • itching
  • localized urticaria
  • facial flushing
  • erectile dysfunction
  • epilepsy
  • amyotrophic lateral sclerosis
  • neuropathy
  • neuritis
  • facial paralysis
  • normal pressure hydrocephalus
  • spinal canal stenosis
  • acute pancreatitis
  • intestinal obstruction
  • hemorrhagic duodenal ulcer
  • appendicitis
  • hemorrhoids
  • abdominal pain
  • intracranial hemorrhage
  • transient ischemic attack
  • atherosclerosis
  • brain infarction exacerbation
  • cerebral hemorrhage
  • liver cancer
  • colorectal carcinoma
  • neoplasm of unspecified type
  • cervical cancer
  • prostate cancer
  • acute renal failure
  • chronic renal failure
  • kidney stones
  • pyelonephritis
  • urinary incontinence
  • rhinitis
  • fibrosing alveolitis
  • pharyngitis
  • pneumonia
  • lung disease
  • death
  • exacerbation of low back pain
  • osteoarthritis
  • arthropathy
  • hypoglycemia
  • hyperkalemia
  • pulmonary embolism
  • purpura
  • bradycardia
  • atrial fibrillation
  • coronary artery disease
  • aortic stenosis
  • heart failure
  • elevated blood pressure
  • acute hepatitis
  • benign pituitary neoplasm
  • otitis media
  • uterine prolapse
  • recurrent cancer
  • fractures
  • chest pain
  • weakness
  • fatigue
  • pain
  • weight gain
  • weight loss
  • hypotension
  • vasculitis
  • hypertonia
  • sensory impairment
  • sensory distortion
  • peripheral neuropathy
  • taste distortion
  • tremor
  • extrapyramidal dysfunction
  • gynecomastia
  • change in bowel habits
  • dry mouth
  • gingival hypertrophy
  • pancreatitis
  • hyperglycemia
  • muscle cramps
  • myalgia
  • leukopenia
  • thrombocytopenia
  • cough
  • dyspnea
  • rhinitis
  • hair loss
  • hyperhidrosis
  • purpura
  • skin discoloration
  • urticaria
  • toxic epidermal necrolysis
  • tinnitus
  • visual disturbances
  • increased frequency of urination
  • nocturia
  • hepatitis
  • jaundice
  • pruritus
  • rash
  • angioedema
  • erythema multiforme
  • myocardial infarction
  • arrhythmia
  • thoracic pain
  • hypotension
  • sinoatrial block
  • atrioventricular block
  • abdominal discomfort
  • precordial pain
  • diarrhea
  • loose stool
  • constipation
  • skin erythema
  • maculopapular rash
  • heaviness
  • warmth
  • decreased glucose tolerance
  • frailty
  • intestinal vascular edema
  • abdominal pain
  • nausea
  • vomiting
  • diarrhea

Not everyone experiences these, and they can vary from person to person.

Storage

This medication is sensitive to light and should be stored in a special container that blocks light. Additionally, to maintain the efficacy of the medication, it should be stored at a temperature between 1 to 30 degrees Celsius.

Appearance and packaging

Appearance

White, round, film-coated tablet with a square shape

Package unit

Bottle packaging - 30 tablets/bottle, Bottle packaging - 300 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.